Home › Companies › Puma Biotechnology, Inc. › 2025-2026
Compiled from SEC Form N-PX filings and Puma Biotechnology, Inc.’s Form 8-K, filed June 16, 2026 (Item 5.07 on EDGAR). Page generated October 18, 2026.
Meeting of June 11, 2026: 10 items on Puma Biotechnology, Inc.’s Form 8-K, filed June 16, 2026: 2 approved · 8 without a stated outcome.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2024-2025 2025-2026
Explore Puma Biotechnology, Inc. in the interactive database Compare manager voting policies
These tallies are Puma Biotechnology, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 16, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Alan H. Auerbach | 37,130,678 | -- | -- | 785,624 | 6,064,713 | 98% | Not verified | — |
| Elect Director: Alessandra Cesano | 37,472,173 | -- | -- | 444,129 | 6,064,713 | 99% | Not verified | — |
| Elect Director: Allison Dorval | 37,447,432 | -- | -- | 468,870 | 6,064,713 | 99% | Not verified | — |
| Elect Director: Michael P. Miller | 37,220,974 | -- | -- | 695,328 | 6,064,713 | 98% | Not verified | — |
| Elect Director: Jay M. Moyes | 36,586,798 | -- | -- | 1,329,504 | 6,064,713 | 96% | Not verified | — |
| Elect Director: Adrian M. Senderowicz | 37,217,253 | -- | -- | 699,049 | 6,064,713 | 98% | Not verified | — |
| Elect Director: Brian Stuglik | 37,372,588 | -- | -- | 543,714 | 6,064,713 | 99% | Not verified | — |
| Elect Director: Troy E. Wilson | 32,546,955 | -- | -- | 5,369,347 | 6,064,713 | 86% | Not verified | — |
| 2. The selection of KPMG LLP as the Company's independent registered accounting firm for the fiscal year ending December 31, 2026 | 42,612,940 | 1,328,476 | 39,599 | -- | 0 | 97% | Approved | — |
| Proposal 3: The Company's stockholders voted to approve, on an advisory basis, the compensation of the Company's named executive officers | 29,326,673 | 7,878,580 | 711,049 | -- | 0 | 79% | Approved | — |
Source: Puma Biotechnology, Inc., Form 8-K, filed with the SEC on June 16, 2026 — read the filing on EDGAR.
Each item below shows how the 168 asset managers that disclosed a Puma Biotechnology, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Puma Biotechnology, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 5 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of directors to serve for a one-year term: Adrian M. Senderowicz
Puma Biotechnology, Inc.’s own tally for this item (“Elect Director: Adrian M. Senderowicz”): 37,217,253 for, 699,049 withheld, per its Form 8-K filed June 16, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 60 asset managers below reported 10,867,230 for, 14,831 withheld, 2 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,549,086 | 0 | 2 | 3,009 | For |
| American Century | 1,911,728 | 0 | 0 | 0 | For |
| Fidelity | 993,189 | 0 | 0 | 0 | For |
| BlackRock | 632,585 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 563,500 | 0 | 0 | 0 | For |
| Dimensional | 435,728 | 0 | 0 | 0 | For |
| Goldman Sachs | 302,843 | 0 | 0 | 0 | For |
| Northern Trust | 289,160 | 0 | 0 | 0 | For |
| Russell Investments | 248,058 | 0 | 0 | 0 | For |
| EA Series Trust | 207,872 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 142,300 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 139,101 | 0 | 0 | 0 | For |
| AQR | 118,280 | 0 | 0 | 0 | For |
| Federated Hermes | 115,723 | 0 | 0 | 0 | For |
| Charles Schwab | 114,915 | 0 | 0 | 0 | For |
| SEI | 110,123 | 0 | 0 | 0 | For |
| Equitable | 80,724 | 0 | 0 | 0 | For |
| JPMorgan | 77,640 | 0 | 0 | 0 | For |
| Legg Mason | 67,629 | 0 | 0 | 0 | For |
| WisdomTree | 66,017 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 61,280 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 61,255 | 0 | 0 | 0 | For |
| Putnam | 58,246 | 0 | 0 | 0 | For |
| TIAA | 55,922 | 0 | 0 | 0 | For |
| Nationwide | 53,123 | 0 | 0 | 0 | For |
Showing the 25 largest of 60 asset managers. See all 60 in the interactive database.
Combines 5 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of directors to serve for a one-year term: Alan H. Auerbach
Puma Biotechnology, Inc.’s own tally for this item (“Elect Director: Alan H. Auerbach”): 37,130,678 for, 785,624 withheld, per its Form 8-K filed June 16, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 60 asset managers below reported 10,867,230 for, 14,831 withheld, 2 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,549,086 | 0 | 2 | 3,009 | For |
| American Century | 1,911,728 | 0 | 0 | 0 | For |
| Fidelity | 993,189 | 0 | 0 | 0 | For |
| BlackRock | 632,585 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 563,500 | 0 | 0 | 0 | For |
| Dimensional | 435,728 | 0 | 0 | 0 | For |
| Goldman Sachs | 302,843 | 0 | 0 | 0 | For |
| Northern Trust | 289,160 | 0 | 0 | 0 | For |
| Russell Investments | 248,058 | 0 | 0 | 0 | For |
| EA Series Trust | 207,872 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 142,300 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 139,101 | 0 | 0 | 0 | For |
| AQR | 118,280 | 0 | 0 | 0 | For |
| Federated Hermes | 115,723 | 0 | 0 | 0 | For |
| Charles Schwab | 114,915 | 0 | 0 | 0 | For |
| SEI | 110,123 | 0 | 0 | 0 | For |
| Equitable | 80,724 | 0 | 0 | 0 | For |
| JPMorgan | 77,640 | 0 | 0 | 0 | For |
| Legg Mason | 67,629 | 0 | 0 | 0 | For |
| WisdomTree | 66,017 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 61,280 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 61,255 | 0 | 0 | 0 | For |
| Putnam | 58,246 | 0 | 0 | 0 | For |
| TIAA | 55,922 | 0 | 0 | 0 | For |
| Nationwide | 53,123 | 0 | 0 | 0 | For |
Showing the 25 largest of 60 asset managers. See all 60 in the interactive database.
Combines 5 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: Election of directors to serve for a one-year term: Alessandra Cesano
Puma Biotechnology, Inc.’s own tally for this item (“Elect Director: Alessandra Cesano”): 37,472,173 for, 444,129 withheld, per its Form 8-K filed June 16, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 60 asset managers below reported 10,882,062 for, 1 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,552,096 | 0 | 1 | 0 | For |
| American Century | 1,911,728 | 0 | 0 | 0 | For |
| Fidelity | 993,189 | 0 | 0 | 0 | For |
| BlackRock | 632,585 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 563,500 | 0 | 0 | 0 | For |
| Dimensional | 435,728 | 0 | 0 | 0 | For |
| Goldman Sachs | 302,843 | 0 | 0 | 0 | For |
| Northern Trust | 289,160 | 0 | 0 | 0 | For |
| Russell Investments | 248,058 | 0 | 0 | 0 | For |
| EA Series Trust | 207,872 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 142,300 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 139,101 | 0 | 0 | 0 | For |
| AQR | 118,280 | 0 | 0 | 0 | For |
| Federated Hermes | 115,723 | 0 | 0 | 0 | For |
| Charles Schwab | 114,915 | 0 | 0 | 0 | For |
| SEI | 110,123 | 0 | 0 | 0 | For |
| Equitable | 80,724 | 0 | 0 | 0 | For |
| JPMorgan | 77,640 | 0 | 0 | 0 | For |
| Legg Mason | 67,629 | 0 | 0 | 0 | For |
| WisdomTree | 66,017 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 61,280 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 61,255 | 0 | 0 | 0 | For |
| Putnam | 58,246 | 0 | 0 | 0 | For |
| TIAA | 55,922 | 0 | 0 | 0 | For |
| Nationwide | 53,123 | 0 | 0 | 0 | For |
Showing the 25 largest of 60 asset managers. See all 60 in the interactive database.
Combines 5 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: Election of directors to serve for a one-year term: Allison Dorval
Puma Biotechnology, Inc.’s own tally for this item (“Elect Director: Allison Dorval”): 37,447,432 for, 468,870 withheld, per its Form 8-K filed June 16, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 60 asset managers below reported 10,871,286 for, 10,776 withheld, 1 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,549,087 | 0 | 1 | 3,009 | For |
| American Century | 1,911,728 | 0 | 0 | 0 | For |
| Fidelity | 993,189 | 0 | 0 | 0 | For |
| BlackRock | 632,585 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 563,500 | 0 | 0 | 0 | For |
| Dimensional | 435,728 | 0 | 0 | 0 | For |
| Goldman Sachs | 302,843 | 0 | 0 | 0 | For |
| Northern Trust | 289,160 | 0 | 0 | 0 | For |
| Russell Investments | 248,058 | 0 | 0 | 0 | For |
| EA Series Trust | 207,872 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 142,300 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 139,101 | 0 | 0 | 0 | For |
| AQR | 118,280 | 0 | 0 | 0 | For |
| Federated Hermes | 115,723 | 0 | 0 | 0 | For |
| Charles Schwab | 114,915 | 0 | 0 | 0 | For |
| SEI | 110,123 | 0 | 0 | 0 | For |
| Equitable | 80,724 | 0 | 0 | 0 | For |
| JPMorgan | 77,640 | 0 | 0 | 0 | For |
| Legg Mason | 67,629 | 0 | 0 | 0 | For |
| WisdomTree | 66,017 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 61,280 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 61,255 | 0 | 0 | 0 | For |
| Putnam | 58,246 | 0 | 0 | 0 | For |
| TIAA | 55,922 | 0 | 0 | 0 | For |
| Nationwide | 53,123 | 0 | 0 | 0 | For |
Showing the 25 largest of 60 asset managers. See all 60 in the interactive database.
Combines 5 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: Election of directors to serve for a one-year term: Brian Stuglik
Puma Biotechnology, Inc.’s own tally for this item (“Elect Director: Brian Stuglik”): 37,372,588 for, 543,714 withheld, per its Form 8-K filed June 16, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 60 asset managers below reported 10,871,286 for, 10,776 withheld, 1 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,549,087 | 0 | 1 | 3,009 | For |
| American Century | 1,911,728 | 0 | 0 | 0 | For |
| Fidelity | 993,189 | 0 | 0 | 0 | For |
| BlackRock | 632,585 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 563,500 | 0 | 0 | 0 | For |
| Dimensional | 435,728 | 0 | 0 | 0 | For |
| Goldman Sachs | 302,843 | 0 | 0 | 0 | For |
| Northern Trust | 289,160 | 0 | 0 | 0 | For |
| Russell Investments | 248,058 | 0 | 0 | 0 | For |
| EA Series Trust | 207,872 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 142,300 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 139,101 | 0 | 0 | 0 | For |
| AQR | 118,280 | 0 | 0 | 0 | For |
| Federated Hermes | 115,723 | 0 | 0 | 0 | For |
| Charles Schwab | 114,915 | 0 | 0 | 0 | For |
| SEI | 110,123 | 0 | 0 | 0 | For |
| Equitable | 80,724 | 0 | 0 | 0 | For |
| JPMorgan | 77,640 | 0 | 0 | 0 | For |
| Legg Mason | 67,629 | 0 | 0 | 0 | For |
| WisdomTree | 66,017 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 61,280 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 61,255 | 0 | 0 | 0 | For |
| Putnam | 58,246 | 0 | 0 | 0 | For |
| TIAA | 55,922 | 0 | 0 | 0 | For |
| Nationwide | 53,123 | 0 | 0 | 0 | For |
Showing the 25 largest of 60 asset managers. See all 60 in the interactive database.
Combines 5 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: Election of directors to serve for a one-year term: Jay M. Moyes
Puma Biotechnology, Inc.’s own tally for this item (“Elect Director: Jay M. Moyes”): 36,586,798 for, 1,329,504 withheld, per its Form 8-K filed June 16, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 60 asset managers below reported 10,661,962 for, 12,226 withheld, 207,875 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,547,635 | 0 | 3 | 4,459 | For |
| American Century | 1,911,728 | 0 | 0 | 0 | For |
| Fidelity | 993,189 | 0 | 0 | 0 | For |
| BlackRock | 632,585 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 563,500 | 0 | 0 | 0 | For |
| Dimensional | 435,728 | 0 | 0 | 0 | For |
| Goldman Sachs | 302,843 | 0 | 0 | 0 | For |
| Northern Trust | 289,160 | 0 | 0 | 0 | For |
| Russell Investments | 248,058 | 0 | 0 | 0 | For |
| EA Series Trust | 0 | 0 | 207,872 | 0 | Abstain |
| TARGET PORTFOLIO TRUST | 142,300 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 139,101 | 0 | 0 | 0 | For |
| AQR | 118,280 | 0 | 0 | 0 | For |
| Federated Hermes | 115,723 | 0 | 0 | 0 | For |
| Charles Schwab | 114,915 | 0 | 0 | 0 | For |
| SEI | 110,123 | 0 | 0 | 0 | For |
| Equitable | 80,724 | 0 | 0 | 0 | For |
| JPMorgan | 77,640 | 0 | 0 | 0 | For |
| Legg Mason | 67,629 | 0 | 0 | 0 | For |
| WisdomTree | 66,017 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 61,280 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 61,255 | 0 | 0 | 0 | For |
| Putnam | 58,246 | 0 | 0 | 0 | For |
| TIAA | 55,922 | 0 | 0 | 0 | For |
| Nationwide | 53,123 | 0 | 0 | 0 | For |
Showing the 25 largest of 60 asset managers. See all 60 in the interactive database.
Combines 5 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of directors to serve for a one-year term: Michael P. Miller
Puma Biotechnology, Inc.’s own tally for this item (“Elect Director: Michael P. Miller”): 37,220,974 for, 695,328 withheld, per its Form 8-K filed June 16, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 60 asset managers below reported 10,867,231 for, 14,831 withheld, 1 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,549,087 | 0 | 1 | 3,009 | For |
| American Century | 1,911,728 | 0 | 0 | 0 | For |
| Fidelity | 993,189 | 0 | 0 | 0 | For |
| BlackRock | 632,585 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 563,500 | 0 | 0 | 0 | For |
| Dimensional | 435,728 | 0 | 0 | 0 | For |
| Goldman Sachs | 302,843 | 0 | 0 | 0 | For |
| Northern Trust | 289,160 | 0 | 0 | 0 | For |
| Russell Investments | 248,058 | 0 | 0 | 0 | For |
| EA Series Trust | 207,872 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 142,300 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 139,101 | 0 | 0 | 0 | For |
| AQR | 118,280 | 0 | 0 | 0 | For |
| Federated Hermes | 115,723 | 0 | 0 | 0 | For |
| Charles Schwab | 114,915 | 0 | 0 | 0 | For |
| SEI | 110,123 | 0 | 0 | 0 | For |
| Equitable | 80,724 | 0 | 0 | 0 | For |
| JPMorgan | 77,640 | 0 | 0 | 0 | For |
| Legg Mason | 67,629 | 0 | 0 | 0 | For |
| WisdomTree | 66,017 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 61,280 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 61,255 | 0 | 0 | 0 | For |
| Putnam | 58,246 | 0 | 0 | 0 | For |
| TIAA | 55,922 | 0 | 0 | 0 | For |
| Nationwide | 53,123 | 0 | 0 | 0 | For |
Showing the 25 largest of 60 asset managers. See all 60 in the interactive database.
Combines 5 wordings of this item as funds reported it.
86% Majority: yes · of votes cast
Description as filed by funds: Election of directors to serve for a one-year term: Troy E. Wilson
Puma Biotechnology, Inc.’s own tally for this item (“Elect Director: Troy E. Wilson”): 32,546,955 for, 5,369,347 withheld, per its Form 8-K filed June 16, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 86% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 60 asset managers below reported 8,989,029 for, 961,060 withheld, 931,974 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,547,628 | 0 | 10 | 4,459 | For |
| American Century | 1,911,728 | 0 | 0 | 0 | For |
| Fidelity | 993,189 | 0 | 0 | 0 | For |
| BlackRock | 0 | 0 | 632,585 | 0 | Abstain |
| BRIDGEWAY FUNDS INC | 563,500 | 0 | 0 | 0 | For |
| Dimensional | 435,728 | 0 | 0 | 0 | For |
| Goldman Sachs | 302,843 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 0 | 0 | 289,160 | Withhold |
| Russell Investments | 0 | 0 | 0 | 248,058 | Withhold |
| EA Series Trust | 0 | 0 | 207,872 | 0 | Abstain |
| TARGET PORTFOLIO TRUST | 142,300 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 118,100 | 0 | 21,001 | 0 | Mixed |
| AQR | 118,280 | 0 | 0 | 0 | For |
| Federated Hermes | 115,723 | 0 | 0 | 0 | For |
| Charles Schwab | 114,915 | 0 | 0 | 0 | For |
| SEI | 0 | 0 | 0 | 110,123 | Withhold |
| Equitable | 0 | 0 | 0 | 80,724 | Withhold |
| JPMorgan | 77,640 | 0 | 0 | 0 | For |
| Legg Mason | 9,881 | 0 | 0 | 57,748 | Mixed |
| WisdomTree | 66,017 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 61,280 | 0 | Abstain |
| Delaware/Macquarie | 0 | 0 | 0 | 61,255 | Withhold |
| Putnam | 58,246 | 0 | 0 | 0 | For |
| TIAA | 55,922 | 0 | 0 | 0 | For |
| Nationwide | 41,401 | 0 | 0 | 11,722 | Mixed |
Showing the 25 largest of 60 asset managers. See all 60 in the interactive database.
Combines 2 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: APPROVE AN AMENDMENT TO EXTEND THE EXPIRATION DATE UNTIL OCTOBER 4, 2028 OF A WARRANT HELD BY ALAN H. AUERBACH, AS DESCRIBED IN THE PROXY STATEMENT.
Puma Biotechnology, Inc.’s own tally for this item (“Elect Director: Alan H. Auerbach”): 37,130,678 for, 785,624 withheld, per its Form 8-K filed June 16, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 61 asset managers below reported 5,318,074 for, 5,556,818 against, 9,881 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,540,929 | 11,168 | 0 | 0 | For |
| American Century | 0 | 1,911,728 | 0 | 0 | Against |
| Fidelity | 135,217 | 857,972 | 0 | 0 | Mixed |
| BlackRock | 0 | 632,585 | 0 | 0 | Against |
| BRIDGEWAY FUNDS INC | 0 | 563,500 | 0 | 0 | Against |
| Dimensional | 0 | 435,728 | 0 | 0 | Against |
| Goldman Sachs | 302,843 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 289,160 | 0 | 0 | Against |
| Russell Investments | 248,058 | 0 | 0 | 0 | For |
| EA Series Trust | 207,872 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 142,300 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 118,100 | 21,001 | 0 | 0 | Mixed |
| AQR | 0 | 118,280 | 0 | 0 | Against |
| Federated Hermes | 115,723 | 0 | 0 | 0 | For |
| Charles Schwab | 114,915 | 0 | 0 | 0 | For |
| SEI | 110,123 | 0 | 0 | 0 | For |
| Equitable | 0 | 80,724 | 0 | 0 | Against |
| JPMorgan | 0 | 77,640 | 0 | 0 | Against |
| Legg Mason | 0 | 57,748 | 9,881 | 0 | Mixed |
| WisdomTree | 66,017 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 0 | 61,280 | 0 | 0 | Against |
| Delaware/Macquarie | 0 | 61,255 | 0 | 0 | Against |
| Putnam | 0 | 58,246 | 0 | 0 | Against |
| TIAA | 0 | 55,922 | 0 | 0 | Against |
| Nationwide | 23,301 | 29,822 | 0 | 0 | Mixed |
Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.
Combines 6 wordings of this item as funds reported it.
79% Approved · of votes cast
Description as filed by funds: ADVISORY (NON-BINDING) VOTE TO APPROVE THE COMPENSATION OF PUMA BIOTECHNOLOGY, INC.'S NAMED EXECUTIVE OFFICERS AS DESCRIBED IN THE PROXY STATEMENT.
Puma Biotechnology, Inc.’s own tally for this item (“Proposal 3: The Company's stockholders voted to approve, on an advisory basis, the compensation of the Company's named executive officers”): 29,326,673 for, 7,878,580 against — passed, per its Form 8-K filed June 16, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 3: The Company's stockholders voted to approve, on an advisory basis, the compensation of the Company's named executive officers.”
Support: 79% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,552,083 | 13 | 2 | 0 | For |
| American Century | 0 | 1,911,728 | 0 | 0 | Against |
| Fidelity | 993,189 | 0 | 0 | 0 | For |
| BlackRock | 632,585 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 563,500 | 0 | 0 | Against |
| Dimensional | 435,728 | 0 | 0 | 0 | For |
| Goldman Sachs | 302,843 | 0 | 0 | 0 | For |
| Northern Trust | 289,160 | 0 | 0 | 0 | For |
| Russell Investments | 248,058 | 0 | 0 | 0 | For |
| EA Series Trust | 207,872 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 142,300 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 139,101 | 0 | 0 | 0 | For |
| AQR | 118,280 | 0 | 0 | 0 | For |
| Federated Hermes | 115,723 | 0 | 0 | 0 | For |
| Charles Schwab | 114,915 | 0 | 0 | 0 | For |
| SEI | 110,123 | 0 | 0 | 0 | For |
| Equitable | 80,724 | 0 | 0 | 0 | For |
| JPMorgan | 77,640 | 0 | 0 | 0 | For |
| Legg Mason | 67,629 | 0 | 0 | 0 | For |
| WisdomTree | 66,017 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 61,280 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 61,255 | 0 | 0 | 0 | For |
| Putnam | 58,246 | 0 | 0 | 0 | For |
| TIAA | 55,922 | 0 | 0 | 0 | For |
| Nationwide | 35,023 | 18,100 | 0 | 0 | Mixed |
Fund voting reports, all 59 managers: 8,365,520 for, 2,519,252 against, 2 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ACORN CAPITAL ADVISORS, LLC | 0 | 4,131,299 | 0 | 0 | Against |
| American Century | 0 | 1,933,075 | 0 | 0 | Against |
| ACADIAN ASSET MANAGEMENT LLC | 1,438,583 | 0 | 0 | 0 | For |
| BlackRock | 1,379,726 | 33,339 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 995,010 | 0 | 0 | 0 | For |
| Renaissance | 850,983 | 0 | 0 | 0 | For |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 652,517 | 0 | 0 | 0 | For |
| LSV ASSET MANAGEMENT | 633,398 | 7,800 | 0 | 0 | For |
| State Street | 619,401 | 4,747 | 0 | 0 | For |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 571,300 | 0 | 0 | Against |
| KENNEDY CAPITAL MANAGEMENT LLC | 467,921 | 10 | 0 | 0 | For |
| GLOBEFLEX CAPITAL L P | 349,651 | 0 | 0 | 0 | For |
| Vanguard | 312,945 | 0 | 0 | 0 | For |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 308,643 | 0 | 0 | 0 | For |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 304,501 | 0 | 0 | 0 | For |
| AQR | 261,920 | 0 | 0 | 0 | For |
| Northern Trust | 253,122 | 2,038 | 0 | 0 | For |
| Russell Investments | 251,572 | 0 | 0 | 0 | For |
| Prudential/PGIM | 244,924 | 0 | 0 | 0 | For |
| Federated Hermes | 237,275 | 0 | 0 | 0 | For |
| STATE OF WISCONSIN INVESTMENT BOARD | 208,618 | 0 | 0 | 0 | For |
| Dimensional | 177,338 | 0 | 0 | 0 | For |
| Goldman Sachs | 160,346 | 0 | 0 | 0 | For |
| DE Shaw | 150,368 | 0 | 0 | 0 | For |
| Fidelity | 148,243 | 0 | 0 | 0 | For |
Institutional-manager reports, all 130 managers: 12,320,789 for, 6,773,402 against, 223 not voted. Showing the 25 largest; see all in the interactive database.
Combines 2 wordings of this item as funds reported it.
97% Approved · of votes cast
Description as filed by funds: RATIFICATION OF THE SELECTION OF KPMG LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF PUMA BIOTECHNOLOGY, INC. FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026.
Puma Biotechnology, Inc.’s own tally for this item (“2. The selection of KPMG LLP as the Company's independent registered accounting firm for the fiscal year ending December 31, 2026”): 42,612,940 for, 1,328,476 against — passed, per its Form 8-K filed June 16, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 2: The Company's stockholders ratified the selection of KPMG LLP as the Company's independent registered accounting firm for the fiscal year ending December 31, 2026.”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 61 asset managers below reported 10,303,170 for, 581,603 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,552,094 | 3 | 0 | 0 | For |
| American Century | 1,911,728 | 0 | 0 | 0 | For |
| Fidelity | 993,189 | 0 | 0 | 0 | For |
| BlackRock | 632,585 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 563,500 | 0 | 0 | Against |
| Dimensional | 435,728 | 0 | 0 | 0 | For |
| Goldman Sachs | 302,843 | 0 | 0 | 0 | For |
| Northern Trust | 289,160 | 0 | 0 | 0 | For |
| Russell Investments | 248,058 | 0 | 0 | 0 | For |
| EA Series Trust | 207,872 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 142,300 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 139,101 | 0 | 0 | 0 | For |
| AQR | 118,280 | 0 | 0 | 0 | For |
| Federated Hermes | 115,723 | 0 | 0 | 0 | For |
| Charles Schwab | 114,915 | 0 | 0 | 0 | For |
| SEI | 110,123 | 0 | 0 | 0 | For |
| Equitable | 80,724 | 0 | 0 | 0 | For |
| JPMorgan | 77,640 | 0 | 0 | 0 | For |
| Legg Mason | 67,629 | 0 | 0 | 0 | For |
| WisdomTree | 66,017 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 61,280 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 61,255 | 0 | 0 | 0 | For |
| Putnam | 58,246 | 0 | 0 | 0 | For |
| TIAA | 55,922 | 0 | 0 | 0 | For |
| Nationwide | 35,023 | 18,100 | 0 | 0 | Mixed |
Showing the 25 largest of 61 asset managers. See all 61 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 50,899,456 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 6.98% |
| 2 | American Century | 3.76% |
| 3 | Fidelity | 1.95% |
| 4 | BlackRock | 1.24% |
| 5 | BRIDGEWAY FUNDS INC | 1.11% |
| 6 | Dimensional | 0.86% |
| 7 | Goldman Sachs | 0.59% |
| 8 | Northern Trust | 0.57% |
| 9 | Russell Investments | 0.49% |
| 10 | EA Series Trust | 0.41% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | ACORN CAPITAL ADVISORS, LLC | 8.12% |
| 2 | American Century | 3.80% |
| 3 | ACADIAN ASSET MANAGEMENT LLC | 2.83% |
| 4 | BlackRock | 2.78% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 1.95% |
| 6 | Renaissance | 1.67% |
| 7 | O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 1.28% |
| 8 | LSV ASSET MANAGEMENT | 1.26% |
| 9 | State Street | 1.23% |
| 10 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 1.12% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Vanguard Group | 7.46% | 13F |
| BlackRock | 7.07% | 13F |
| Renaissance Technologies | 3.82% | 13F |
| Millennium Management | 2.90% | 13F |
| Dimensional Fund Advisors | 2.82% | 13F |
| Geode Capital | 2.00% | 13F |
| State Street | 1.80% | 13F |
| AQR Capital | 1.57% | 13F |
| Goldman Sachs | 1.32% | 13F |
| Northern Trust | 1.26% | 13F |
Percentages above are of 50,899,456 shares outstanding, as reported by Puma Biotechnology, Inc. on its Form 10-Q dated May 4, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Puma Biotechnology, Inc.’s 10-Q dated May 4, 2026. This page is a static snapshot rebuilt weekly on October 18, 2026; a live search always shows the current data.
At Puma Biotechnology, Inc.'s shareholder meeting held June 11, 2026, in the 2025-2026 proxy season, 168 asset managers reported how they voted in their SEC Form N-PX filings, covering 2,030 separate fund positions. Their filings are grouped here into 11 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — ADVISORY (NON-BINDING) VOTE TO APPROVE THE COMPENSATION OF PUMA BIOTECHNOLOGY, INC.'S NAMED… — Puma Biotechnology, Inc.'s filing reports the proposal as approved, with 79% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Puma Biotechnology, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 16, 2026.
Puma Biotechnology, Inc. proxy season coverage: 2024-2025 · 2025-2026 (this page).
Download data (CSV): ballot items · votes by manager · column guide.